Cardiff Oncology Inc.

NASDAQ: CRDF · Real-Time Price · USD
2.44
0.00 (0.00%)
At close: Aug 15, 2025, 1:09 PM

Cardiff Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
51.47M 21.66M 16.35M 11.94M
Short-Term Investments
40.28M 53.17M 88.92M 128.88M
Long-Term Investments
n/a n/a n/a 139K
Other Long-Term Assets
69K 1.28M 1.39M 100K
Receivables
773K 288K 771K 535K
Inventory
n/a n/a n/a n/a
Other Current Assets
2.54M 2.3M 5.25M n/a
Total Current Assets
95.05M 77.41M 111.28M 146.13M
Property-Plant & Equipment
2.07M 2.95M 3.52M 3.18M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.14M 4.22M 4.91M 3.42M
Total Assets
97.19M 81.64M 116.19M 149.54M
Account Payables
4.82M 1.97M 1.96M 1.44M
Deferred Revenue
n/a n/a n/a 4.53M
Short-Term Debt
n/a n/a 675K 551K
Other Current Liabilities
2.75M 5.05M 2.65M 926K
Total Current Liabilities
13.43M 10.44M 7.81M 6.56M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
813K 1.46M 2.04M 2.57M
Total Liabilities
14.24M 11.9M 9.85M 9.13M
Total Debt
1.52M 2.15M 2.71M 3.12M
Common Stock
7K 4K 4K 4K
Retained Earnings
-384.18M -339.54M -298.1M -259.81M
Comprehensive Income
34K -67K -395K -142K
Shareholders Equity
82.95M 69.74M 106.34M 140.42M
Total Investments
40.28M 53.17M 88.92M 128.88M